Close the Gap with the Most Effective Diabetic Retinopathy Screening Solution on the Market
Diabetic retinopathy is highly treatable if detected early through annual eye screening: only 50% of people with diabetes are getting their annual screening. Untreated diabetic retinopathy may lead to blindness and vision loss which costs the US healthcare system $134B annually*. We are on a mission to resolve this problem.
If You Move up One Star in the CMS STAR Rating by Closing the Diabetic Retinopathy Screening Care Gap, You Will Create $30/Patient in Value.
Diabetic retinopathy screening is one of 5 HEDIS diabetic measures under the Effectiveness of Care. The 5 measurements are:
BP
A1c
Kidney health
Statin therapy
Eye exam
Out of those 5 exams, only the eye exam requires a separate appointment with a specialist. The rest are collected during standard wellness visits. You are at the mercy of the specialist in order to close this gap.
We remove all of that hassle and empower you to control the whole process.
That’s Not All..
Our solution was designed by physicians to ensure we maximize patient outcomes with the least disruption to physician workflows:
All of this leads to be better images, less time chasing paperwork, lower financial risk and no disruption to current workflow.
